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Introduction
Bloodstream infections (BSI) still account for significant
morbidity and mortality.
Objectives
The objective of this study was to describe the epide-
miology, etiology, sources and adequacy of empiric anti-
microbial treatment in BSI.
Methods
A retrospective study about all BSI diagnosed during
one year. The pattern resistant pathogen study was
EPINE-EPPS project.
Results
340 patients were included. Median age was 74.5 years
[interquartile range (IQR), 58.5-80.5]; acute physiology
and chronic health evaluation (APACHE II) score was
13 (IQR, 7-29).
BSI were community-acquired in 56% of the cases. The
most common source of BSI was urinary tract (48.3%),
intra-abdominal (25.6%) and lower respiratory tract
infections (18.6%). The most commonly isolated microor-
ganisms were: Escherichia coli, K. pneumoniae, S.aureus
(15% oxacilin resistant) and S. pneumoniae. The 8.6% of
enterobacteracea family produced extended-spectrum B-
lactamasas (ESBLs). Inappropriate treatment was
observed in 24.5% and crude mortality rate was 7.7%.
28% BSI were nosocomial-acquired. The sources of
BSI were unknown in 31.7% of the cases and catheter-
related in 25.7%. The secondary sources of BSI were
intra-abdominal in 57% of the cases. The most common
isolated microorganisms were: S.epidermidis and other
coagulasa negative, Candida, S. aureus (36% oxacilin
resistant) and E. coli. 25% of enterobacteracea family
were ESBLs. We found 5 BSI caused by Acitetobacter
carbapenem (CPM) resistant and 2 BSI by P. aeruginosa
CPM resistant. Inappropriate treatment was observed in
52.5% and mortality rate was 28.7%.
Health-care related BSI produced 15.1% of the cases.
The source of BSI were unknown in 22.6% and catheter-
related in 11.3%. The secondary sources of BSI were
urinary tract (60%), intra-abdominal (31.4%) and respira-
tory tract infections(8.6%). The most common microor-
ganisms were: E.coli, S.aureus (25% oxacilin resistant), S.
epidermidis and K.pneumoniae. Inappropriate treatment
was noticed in 34% and mortality rate was 17%.
Conclusion
The knowledge of local epidemiology is a capital infor-
mation to improve empiric antimicrobial treatment and
to reduce mortality-related inappropriate treatment.
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